drugset / Trial / NCT02120196
Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of the study is to compare the effectiveness of rifaximin versus norfloxacin for secondary prevention of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.
Timeline
- Start
- 2014-01
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Norfloxacin | Small molecule | 400 mg | — |
| Subject | Rifaximin | Other / unclassified | 1200 mg | — |